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Background: There has not been a comprehensive multi-center study investi-
gating the microbial profile of community acquired pneumonia (CAP) in
Taiwan.
Methods: A prospective study of adult CAP patients requiring hospitalization
between December 2001 and April 2002 was carried out in 13 hospitals in Taiwan.Elsevier Ltd. All rights reserved.
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T.-L. Lauderdale et al.1080Etiology was determined based on laboratory data from blood and sputum cultures
plus serology from paired serum and urine antigen detection tests.
Results: Etiology was assigned to 99 (58.9%) of the 168 patients having the most
complete data for etiology determination, with mixed infection in 21 (12.5%)
patients. More than half (51.8%) of the patients were460 years and 63.7% of the
patients were males. The most common etiologic agent was Streptococcus
pneumoniae (40, 23.8%), the majority (60%, 24 cases) of which was detected by
positive urine antigen test. Other common agents included Mycoplasma pneumoniae
(24, 14.3%), Chlamydia pneumoniae (12, 7.1%), Influenza A virus (11, 6.5%),
Klebsiella pneumoniae (8, 4.8%) and Haemophilus influenzae (8, 4.8%). The
prevalence of S. pneumoniae and M. pneumoniae was highest in patients460 years
(25/87, 28.7%), ando44 years (12/59, 19%), respectively; while K. pneumoniae
comprised a larger proportion (4/22, 18%) in the 45–59 years group.
Conclusions: S. pneumoniae was the most common etiology agent in adult patients
hospitalized due to CAP in Taiwan and the spectrum of other major pathogens was
similar to studies conducted elsewhere in the world. Empiric treatment recommen-
dations developed in other parts of the world may be appropriately adapted for local
use after taking into account local resistance profiles. Our data also support the
recommendation that urine antigen test be added as an adjunct to adult CAP
etiology diagnosis protocol.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Despite the availability of potent new antimicro-
bials, advanced supportive therapy, and effective
vaccines, community acquired pneumonia (CAP)
remains a leading cause of morbidity and a
significant cause of mortality worldwide, with up
to 30% of patients requiring hospitalization and a
mortality rate of 12% or higher in high-risk
patients.1–10 Because delayed treatment increased
the risk for mortality, the management of CAP
requires prompt diagnosis in order to initiate
proper empiric antibiotic therapy based on the
knowledge of the likely etiologic agent.11,12 Several
comprehensive CAP treatment guidelines are avial-
able in Western countries based on studies con-
ducted in those parts of the world.8,10,13–15
The most commonly used and accepted labora-
tory methods in determining the etiologic agents of
CAP to date included blood and sputum cultures,
and serology.16 Despite extensive diagnostic test-
ing, an etiologic agent is often undetermined in as
much as one-third to over half of the cases studied.
In recent years, urine antigen detection assay has
become an accepted adjunct to culture for deter-
mining the etiology of CAP in adults.8,15,17,18
In Taiwan, pneumonia was the 7th and 8th
leading cause of death between 1994 and 2002.
With the exception of a few reports on the role of
individual CAP pathogen,19–22 there has not been a
comprehensive prospective study investigating the
etiology profile of CAP in Taiwan. In a study of
antibiotic usage in hospitals in Taiwan, it was found
that the most common community acquired infec-tion was pneumonia, which accounted for 24% of
community acquired infection cases and a putative
agent was isolated in o30% of CAP cases.23 Thus,
we initiated a prospective study of unselected
adult CAP patients admitted to hospitals in Taiwan
and applied results from microbiology cultures,
serology and urine antigen detection assays to
elucidate the etiologic agents in those patients.Methods
Patients
Between December 1, 2001 and April 30, 2002,
patients who were416 year old, and who were
admitted to internal medicine and pulmonary
services in 13 hospitals throughout Taiwan with a
dianosis of
’ ’
lower respiratory infection’’ were
examined for the possibility of CAP. The 13
hospitals included 5 medical centers, 7 regional
hospitals, and 1 local hospital, with an average
number of 1640, 666, and 210 beds, respectively.
Patients who were enrolled must fulfill the follow-
ing criteria: A chest radiograph taken within 48 h of
admission revealing a new infiltrate consistent with
pneumonia, and at least one of the following: fever
(438.3 1C) or chills, or hypothermia (o35.5 1C),
productive cough, or abnormal white blood cell
count (411 109/L, oro3 109/L) with or without
an abnormal differential. Patients who had stayed
in a long-term care facility or nursing home over 21
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committee on human research at our institutes.
Data and specimen collection
Patient data was collected using a standardized
questionnarie. Information collected included de-
mogrphic characteristics, history, physical exam-
ination and laboratory results at presentation and
during hospital course, additional diagnostic stu-
dies and hospital course. Results of microbiology
work-up on patient sputum, blood, and pleural
samples performed by the hospital were recorded.
A sample of acute serum collected within 24 h of
admission, a convalescent serum collected be-
tween 4 and 6 weeks after admission, and a urine
sample collected within 48 h of admsision were
obtained and stored frozen.
Serology and urine antigen testing
Serologic assays were used to detect IgG and IgM
antibodies. Antibodies to Chlamydia pneumoniae
and Legionella pneumophila (serotypes 1, 4, 6, 8
mixture); and viral agents adenovirus, influenza A,
influenza B, parainfluenza 1–4, and respiratory
syncytial virus; were determined using immuno-
fluorescence assay (EUROIMMUN, Germany). Anti-
bodies to Mycoplasma pneumoniae were
determined by enzyme-linked immuosorbent assay
(ELISA) (Savyon Diagnostics, Ashdod, Israel). Detec-
tion of Streptococcus pneumoniae and L. pneumo-
phila antigens in urine was performed using an
immunochromatographic assay (Binax NOW, Binax
Inc., Maine, USA).
Assignment of etiology
Establishment of infection with specific etiologic
agents included definite and probable categories
following published criteria and guidelines.1,3,8 A
definite agent was assigned when (1) the isolate was
cultured from blood or pleural fluid, (2)X4 fold
rise in IgG antibody titre to L. pneumophila
(toX1:128), C. pneumoniae (toX1:256), or to any
of the respiratory virus antigens tested, or a
seroconversion of antibodies to M. pneumoniae
based on manufacturer’s criteria, (3) Detection of
L. pneumophila antigen in urine, or (4) Detection of
S. pneumoniae antigen in urine plus isolation of
S. pneumoniae from purulent sputum. A probable
agent was assigned when (1) A pathogen was
isolated as a predominant organism from a purulent
sputum in which a compatible organism was seen as
a predominant organism or in at least moderateamount on Gram stain; or (2) Detection of S.
pneumoniae antigen in urine.
Statistics
Significance of differences in frequencies and
proportions was tested by the w2 test with Yates’
correction using Epi Info 6.04 (CDC, Atlanta, GA), a
database and statistical program for public health.
Multiple logistic regression was used to identify risk
factors for mortality using SAS 8.2 (SAS Institute
Inc., Cary, NC).Results
A total of 468 adult patients were enrolled in the
study, of which 20 were excluded including 13 who
stayed in a long term care facility over 21 days and
7 with no questionnaire. From these 448 patients,
the etiology profile of 168 patients (37.5%) who had
the most complete and definite laboratory data was
analyzed in detail. The other patients either had no
blood or sputum culture or lacked convalescent
serum. The 168 patients included 158 who had
paired serum, blood (or pleural fluid) and sputum
cultures, and urine for antigen testing and 10
patients with meaningful positive blood cultures (3
S. pneumoniae, 3 K. pneumoniae, 2 Escherichia
coli, 1 Haemophilus influenzae, and 1 Staphylo-
coccus aureus with beta-streptococci). Patient
demographic and characteristics of these 168
patients are presented in Table 1. The age
distribution, sex, and proportions of patients with
different characteristics of these 168 patients
presented in Table 1 were very similar to all 448
patients.
Over half (51.8%) the patients wereX60 years
and a larger proportion of the patients were males
(63.7%). A total of 53.6% of the patients had at least
one comorbidity present, and 32.2% had two or
more comorbidities (data not shown). The most
common radiography finding was in the right lower
lobe (51.1%) with 39.7% of patients having multi-
lobar infiltration. Very few patients reported having
been vaccinated for H. influenzae (2, 1.2%),
pneumococci (2, 1.2%), and influenza (9, 5.4%)
(data not shown). Only less than half (44.6%) of the
patients knew for certain they did not receive
antibiotics prior to admission.
Using the definite and probable diagnosis criter-
ia, 121 etiologic agents (84 in definite and 37 in
probable category) were assigned to 99 (58.9%) of
the 168 patients (Table 2). Combining definite and
probable agents, the most common pathogen
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Table 1 Demographic and characteristics of 168
hospitalized adult CAP patients in Taiwan.
Variable No. of patients
(%)
Age, mean+SD (range) 56.1+22.8 years
(17–99 years)
17–44 years 59 (35.1)
45–59 years 22 (13.1)
X60 years 87 (51.8)
Male 107 (63.7)
Comorbidity present 90 (53.6)
Pulmonary 35 (20.8)
Hypertension 37 (22.0)
Cardiovascular 34 (20.2)
Diabetes mellitus 21 (12.5)
Renal 21 (12.5)
Neurologic 14 (8.3)
Neoplastic 9 (5.4)
Hepatic 8 (4.8)
Immunosuppression 2 (1.2)
Clinical presentation on
admission
Cough 109 (64.9)
Fever (38.2 1C) or chills 134 (79.8)
Hypothermia 4 (2.4)
Leukocytosis 91 (54.2)
Leukopenia 4 (2.4)
Abnormal differential 21 (12.5)
Radiography presentationsy
Right lower lobe 86 (51.1)
Left lower lobe 65 (38.7)
Right middle lobe 41 (24.4)
Right upper lobe 22 (13.1)
Left upper lobe 14 (8.3)
Multi-lobar involvement 67 (39.7)
Antibiotic use prior to admission
No antibiotic used 75 (44.6)
Unknown or unreliable 66 (39.3)
Antibiotic used 27 (16.1)
Mortality 14 (8.3)
Data are number (percentage) of patient for each
variable except patient age.
yLocation of radiography finding: data represent single
and multi-lobar infiltration combined.
T.-L. Lauderdale et al.1082identified was S. pneumoniae (40, 23.8%), followed
by M. pneumoniae (24, 14.3%), C. pneumoniae (12,
6.5%), Influenza A (11, 6.5%), H. influenzae (8,
4.8%), and K. pneumoniae (8, 4.8%). Coinfection
with more than one etiologic agent was found in 21
(12.5%) patients. The most common coinfection
combination was S. pneumoniae with another agent
(12, 7.1%), of which 6 (3.6%) were with M.
pneumoniae. The etiology of 69 (41.1%) patients
was unknown. The rate of etiology unknown was
not significantly different (P40:05) among the
patients having no prior antibiotic use (48.0%, 36/75), and uncertain antibiotic use history (33.3%,
22/66), and antibiotic used group (40.7%, 11/27).
Of the 40 S. pneumoniae cases in the present
study, 12 were in the definite category, 5 of which
had positive blood cultures, 4 of them had positive
urine antigen results also; the other 7 cases had S.
pneumoniae in purulent sputum cultures and
positive urine antigen tests. Of the other 28 S.
pneumoniae cases in the probable category, 4 had
positive sputum culture with compatible Gram
stain but negative urine antigen test; 24 had
negative sputum culture but positive urine antigen
test. Only one of the 24 culture-negative, urine
antigen-positive patients had received pneumon-
coccal vaccine 8 months prior to hospitalization;
and 14 patients either had received antibiotics or
were not certain about antibiotic usage.
Patients were also divided into three groups by
age, 17–44 years (59, 35.1%), 45–59 years (22,
13.1%),X60 years (87, 51.8%), to look for patho-
gens more commonly associated with an age group.
The most common etiologic agent in the younger
(17–44 years) group was M. pneumoniae (19.0%),
while in the older (X60 years) group the most
common pathogen was S. pneumoniae (28.7%). K.
pneumoniae comprised significantly larger propor-
tion in the 45–59 years group compared to the
other two age groups (18.2% vs. 1.7% and 3.4%;
Po0:01). Patients in the 45–59 years group also had
a smaller percentage of etiology unknown (18.2%
vs. 38.9% and 48.3%, Po0:05) (Table 3).
The mortality rate was 8.3% (14/168). Of the 14
patients who died, etiologic agents was identified
in 11 patients, including 5 S. pneumoniae (1 with M.
pneumoniae), 3K. pneumoniae, 1 E. coli, 1
Staphylococcus aureus with beta-streptococci,
and 1 C. pneumoniae; 4 of whom were bacteremic
(S. pneumoniae, K. pneumoniae, E. coli, and S.
aureus with beta-streptococci). The mean age of
the patients who died was 75.0 years compared to
55.0 years in the patients who survived. Univariate
analysis showed that age (Odds ratio (OR), 8.67,
95% confidence interval (CI), 1.88–40.06; Po0:01),
comorbidities (OR, 1.75; CI 1.18 –2.58; Po0:01),
and bacteremia (OR 5.56; CI, 1.63–18.88; Po0:01)
were risk factors associated with mortality. Multi-
ple regression analysis also showed that age (OR
1.75; CI 1.164—2.633; Po0:01) and bacteremia
(OR 5.55; CI 1.53–20.12; Po0:01) were risk factors
associated with mortality.Discussion
Many studies conducted in North America, Europe,
and other Asian countries have found S. pneumoniae
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Table 2 Etiologic agents of 168 adult community acquired pneumonia patients requiring hospitalization in
Taiwan.
Etiologic agent Diagnostic category, No. (%) Total
Definite Probable
Streptococcus pneumoniae 12 (7.1) 28 (16.1) 40 (23.8)
Haemophilus influenzae 2 (1.2) 6 (3.6) 8 (4.8)
Staphylococcus aureus 3 (1.8) 0 3 (1.8)
Beta-Streptococci 2 (1.2) 0 2 (1.2)
Gram-negative bacilli
Klebsiella pneumoniae 5 (3.0) 3 (1.8) 8 (4.8)
Escherichia coli 3 (1.8) 0 3 (1.8)
Mycoplasma pneumoniae 24 (14.3) z 24 (14.3)
Chlamydia pneumoniae 12 (7.1) z 12 (7.1)
Legionella pneumophila 2 (1.2) z 2 (1.2)
Influenza A virus 11 (6.5) z 11 (6.5)
Respiratory syncytial virus 2 (1.2) z 2 (1.2)
Adenovirus 2 (1.2) z 2 (1.2)
Parainfluenza virus 2 (1.2) z 2 (1.2)
Mycobacteria tuberculosis 2 (1.2) z 2 (1.2)
Total no. of patients (%)y 73 (43.5) 36 (21.4) 99 (58.9)y
Values for mixed infections are included for each of the infecting organisms.
yDue to the presence of multiple organisms in some patients, the total number of patients is lower than the sum of patients
for each agent.
zDiagnostic category not available for specific pathogen.
Table 3 Etiologic agents of 168 adult community acquired pneumonia patients requiring hospitalization in
Taiwan by age group.
Etiologic agent, (Definite and
probable combined)
No. (%) of patients, by age group
17–44 years
(n ¼ 59)
45–59 years
(n ¼ 22)
4 ¼ 60 years
(n ¼ 87)
P
Streptococcus pneumoniae 11 (17.2) 4 (18.2) 25 (28.7) NS
Haemophilus influenzae 5 (8.6) 1 (4.5) 2 (2.3) NS
Staphylococcus aureus 2 (3.4) 0 1 (1.1) NS
Beta-Streptococci 0 0 2 (2.3) NS
Gram-negative bacilli
Klebsiella pneumoniae 1 (1.7) 4 (18.2) 3 (3.4) o0.01
E. coli 0 0 3 (3.4) NS
Mycoplasma pneumoniae 12 (19.0) 4 (18.2) 8 (9.2) NS
Chlamydia pneumoniae 3 (5.1) 3 (13.6) 6 (6.9) NS
Legionella pneumophila 1 (3.3) 1 (4.5) 0 NS
Influenza A virus 5 (8.6) 2 (9.0) 4 (4.6) NS
Respiratory syncytial virus 1 (1.2) 0 1 (1.1) NS
Adenovirus 2 (6.6) 0 0 NS
Parainfluenza virus 1 (3.3) 1 (4.5) 0 NS
Mycobacteria tuberculosis 0 0 2 (2.3) NS
No of patients with:
Single infection 28 (47.5) 16 (72.7) 34 (39.1) 0.02
Mixed infection 8 (13.6) 2 (9.1) 11 (12.6) NS
Etiologic agent not identified 23 (38.9) 4 (18.2) 42 (48.3) 0.03
w2 analysis of proportions in the three strata; NS, not significant (40.05).
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Table 4 Comparison of the proportions of etiology agents of hospitalized adult CAP patients in Taiwan and other countries.
Condition and Etiologic agent Taiwan (n ¼ 168) UK (n ¼ 267) USA (n ¼ 2776) Finland
(n ¼ 135)
Netherlands
(n ¼ 334)
Israel
(n ¼ 346)
Thailand
(n ¼ 147)
Japan
(n ¼ 326)
Reference no. 6 3 5 1 2 7 4
Month/year started Dec 2001 Oct 1998 1991 Sept 1981 Jan 1991 Nov 1991 Sept 1998 July 1994
Length of study 5 months 1 year 1 year 1 year 2 years 3 months 1 year 2 years 7
months
3 year
Age, mean (range), years 56.1 (17–99) 65.4 (18–97) — (418) — (15–92) — (17–92) 49.3 (17–94) 58.9 () 65.2 (18–93)
Male 63.7% 51% 51.4% — 58.4% 54% 67.3% 72%
Etiologic agent
S. pneumoniae 24% 48% 13% 47% 27% 43% 22% 23%
H. influenzae 5% 7% 7% 4% 8% 5.5% 3% 7%
M. pneumoniae 14% 3% 32.5% 5% 6% 29% 7% 5%
C. pneumoniae 7% 13% 9% 16% 3% 18% 16% 3%
Enterobacteriaceae 6.5% 1% 3% 3% 12% 4%
S. aureus 2% 1.5% % 1% 3% 3%
L. pneumophila 1% 3% 3% 2% 16% 5% o1%
Viruses 10% 23% 12% 10% 8% 10% — 4%
M. tuberculosis 1% 1% 2% 1.5%
Mixed infection 12.5% 28% — 17% 10% 39% 6% 4%
Mortality 8.3% 15% 9% — 8% — 16% –53% 6%
Etiology unknown 41% 25% 60% 33% 45% 19% 29% 39%
—, No data.
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Community acquired pneumonia in Taiwan 1085to be the most common etiologic agent in adult CAP
patients, followed by atypical pathogens M. pneu-
moniae and C. pneumoniae, H. influenzae, and
viruses.1–7 Other pathogens such as K. pneumoniae,
E. coli, P. aeruginosa, S. aureus, L. pneumophila,
and M. tuberculosis also accounted for various
percentages as CAP agents. The rank orders of these
etiologic agents varied depending on laboratory
testing methods, diagnostic criteria and categories.
We also found S. pneumoniae (23.8%) to be the most
common identifiable etiologic agent of adult CAP
patients admitted to hospitals in Taiwan, followed
by M. pneumoniae (14.3%), C. pneumoniae (7.1%).
The contribution of these 3 agents in CAP varied
widely in other studies, ranging between 13–48% (S.
pneumoniae), 3%–32.5% (M. pneumoniae), and
3–18% (C. pneumoniae).1–7 A comparison of patient
demographics and etiology profiles from the present
study with several studies conducted in other
countries is presented in Table 4.
Despite applying blood and sputum microbiology
cultures, paired serum serology, and urine antigen
tests, the etiology was identified in only 58.9% of
the patients in the present study. Two major CAP
management guidelines consider the pneumoncoc-
cal urinary antigen assay as a recommended and
acceptable diagnostic test to augment the standard
microbiology cultures for adult cases,8,15 Out of the
40 S. pneumoniae cases identified in the present
study, 24 were due to a positive urine antigen test
alone. Studies have shown excessive and in-
appropriate antibiotic use in Taiwan outpatients,
especially in respiratory infections.23,24 In a study
of patients seen at the emergency department of a
major medical center in Taiwan, antimicrobial
activity in urine was found in half of patients
admitted to the hospital, which resulted in masked
diagnosis of infectious diseases.25 Although the
rates of etiology unknown among the patients
having received prior antibiotics and those having
no prior antibiotic use were similar in the present
study, it is still possible that prior antimicrobial use
affected the recovery of CAP bacterial pathogens in
routine microbiology cultures, which contributed
both to the etiology unknown cases (41.1%) and the
S. pneumoniae cases being diagnosed by urine
antigen alone.
In the present study, coinfection was found in
12.5% of patients. Mixed infections involving multi-
ple bacterial pathogens or a combination of
bacterial and viral pathogen is not an uncommon
finding in CAP although rates of coinfection varied
(4–39%, Table 4). Three studies conducted in
Western countries also determined antibodies to
different S. pneumoniae antigens in addition to
determining antibodies to atypical bacterial andviral agents, and employing urine antigen test.2,5,6
These studies found higher mixed infection rates
(17–39%), with S. pneumoniae mixed with M.
pneumoniae, or C. pneumoniae mixed with another
pathogen being the most common findings. Even
though we did not test for antibodies to S.
pneumoniae antigens, we still found S. pneumoniae
to be the most common pathogen mixed with other
pathogens in our coinfection cases.
There were more males than females in hospita-
lized adult CAP patients in the studies presented in
Table 4, but the proportion was higher in Asian
countries (67.3% in Thailand, 72% in Japan) than
Western countries (51–58%).1–7 We also found a
higher proportion (63.7%) of patients being males in
our study. The reason for this is unknown but it may
be related to smoking as higher percentage of
males are smoker in Taiwan, Thailand and Japan
where smoking prevalence was 40–60% and o10%
for males and females, respectively; compared to
smoking prevalence of 20–30% for both males and
females in Western countries such as US and UK.26
One limitation of the present investigation is that
other studies have found seasonal variations in CAP
with higher incidences for all age groups in the
winter and spring.2,5,6 Because our study was
conducted over a 5-month period from December
to April, we were not able to determine seasonal
variations in etiology profiles. It is possible that the
proportion of each of the etiologic agent in the
warmer months could be different since there was
a report of 13 severe CAP cases due to Acineto-
bacter baumannii in a Taiwan hospital, 11 (85%) of
which were found between April and October.19
Another limitation is that even though we tested
patient urines for L. pneumophila antigen, we did
not culture for Legionella spp., thus the role of
Legionella spp. in the present study may be
underestimated.
This is the first report of a national multi-center
prospective study of the etiology of adult patients
with CAP requiring hospitalization in Taiwan. Our
results indicated that despite differences in cli-
mate temperate, the etiology profile in Taiwan is
similar to that of Western and other Asian coun-
tries, with S. pneumoniae being the most common
pathogen, followed by M. pneumoniae and C.
pneumoniae; albeit differences in the proportions
of each etiologic agent exist. Gram-negative
bacilli, especially K. pneumoniae, also play an
important role in hospitalized CAP patients in
Taiwan, especially in the 45–59 years age group.
Our results also supports the recommendation that
urine antigen test be added to the diagnostic
protocol for adult CAP patients. High rates of
resistance in S. pneumoniae and other bacterial
ARTICLE IN PRESS
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Empiric treatment guidelines developed in other
parts of the world may be appropriately adapted
for use in Taiwan after taking into account local
resistance trends.Acknowledgements
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